United States Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report Download FREE Resources

Published: July 09, 2025 Report Code: GDME25930CCDB-ST

Select Item

GlobalData’s “United States Computed Tomography (CT) Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Computed Tomography (CT) Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems and 16-slice and below CT Systems

The United States Computed Tomography (CT) Systems Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Computed Tomography (CT) Systems Market.
• Global corporate-level profiles of key companies operating within the United States Computed Tomography (CT) Systems Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Computed Tomography (CT) Systems is segmented as follows –

• 256-320 slice CT Systems

• 128-slice CT Systems

• 64-slice CT Systems

• 20-40 slice CT Systems

• 16-slice and below CT Systems

Reasons to Buy

The United States Computed Tomography (CT) Systems Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Canon Medical Systems Corp
GE HealthCare Technologies Inc
Neusoft Medical Systems Co Ltd
Philips Healthcare Informatics Inc
Siemens Healthineers AG

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Computed Tomography (CT) Systems Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Computed Tomography (CT) Systems Market, United States 9

3.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2018-2033 9

3.2 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033 12

3.3 Computed Tomography (CT) Systems Market, United States, Average Price ($) , 2018-2033 14

3.4 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2024 16

4 Overview of Key Companies in United States, Computed Tomography (CT) Systems Market 18

4.1 Siemens Healthineers AG 18

4.1.1 Company Overview 18

4.2 GE HealthCare Technologies Inc 18

4.2.1 Company Overview 18

4.3 Philips Healthcare Informatics Inc 18

4.3.1 Company Overview 18

4.4 Canon Medical Systems Corp 18

4.4.1 Company Overview 18

4.5 Neusoft Medical Systems Co Ltd 19

4.5.1 Company Overview 19

5 Computed Tomography (CT) Systems Market Pipeline Products 20

6 Financial Deals Landscape 21

6.1 Debt Offerings 21

6.1.1 Stryker Raises USD883.83 Million Public Offering of

3.375% Notes Due 2032 21

6.1.2 Stryker Raises USD662.87 Million in Public Offering of

3.625% Notes Due 2036 23

7 Recent Developments 24

7.1 Corporate Communications 24

7.1.1 Jun 17, 2025: ConvaTec Receives FDA 510(k) Clearance for Cure Pocket Catheter Kit 24

7.1.2 Feb 21, 2025: Noris Medical Receives FDA 510(k) Clearance for LONGY-N Implant 24

7.1.3 Oct 02, 2024: Koning Health Appoints David Bodne and Richard Reaven as Co-Chief Medical Officers 24

7.1.4 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer 25

7.1.5 Sep 23, 2024: Accellix Names Greg Hamilton as Chief Executive Officer 25

7.2 Financial Announcements 26

7.2.1 Apr 17, 2025: GE HealthCare to Announce First Quarter 2025 Results on April 30, 2025 26

7.2.2 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 26

7.2.3 Mar 12, 2025: Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business 27

7.2.4 Jan 23, 2025: GE Aerospace Announces Fourth Quarter 2024 Results 28

7.2.5 Dec 12, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2024 Results on February 13, 2025 29

7.2.6 Nov 12, 2024: Fonar Announces Financial Results for the 1st Quarter of Fiscal 2025 29

7.2.7 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results 30

7.2.8 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 30

7.3 Government and Public Interest 30

7.3.1 May 27, 2025: Avenacy Announces Launch of Doxycycline for Injection, USP in the U.S. Market 30

7.3.2 May 27, 2025: CeleCor Completes Multinational Phase 3 Registrational Study of Novel Anti-platelet Agent for Heart Attack 31

7.3.3 Apr 14, 2025: ACR Statement on JAMA CT Scan Radiation Study (Smith-Bindman, et al) 33

7.3.4 Feb 13, 2025: Unimom Receives Additional 510(K) Clearance For VIVACE Powered Breast Pump 33

7.3.5 Feb 10, 2025: GE Healthcare Management to Present at Upcoming Investor Conference 34

7.3.6 Jan 29, 2025: Update on the Episurf MTP Implant – Response to FDA Submitted 34

7.3.7 Dec 20, 2024: FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities 34

7.3.8 Dec 03, 2024: Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed 36

7.3.9 Oct 15, 2024: Electronic Medical Devices, X-ray Imaging and Radiation Therapy: What to Know and How to Prevent Damage 36

7.3.10 Aug 23, 2024: Moderna Receives Approval for RSV Vaccine mRESVIA 37

7.3.11 Aug 23, 2024: Nurexone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences 38

7.3.12 Jul 09, 2024: ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments 39

7.4 Other Significant Developments 40

7.4.1 Jun 16, 2025: Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients 40

7.4.2 Apr 08, 2025: 3D Printing and Visualization: A New Dimension of CT and MRI 41

7.4.3 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 41

7.4.4 Jan 14, 2025: National Institutes of Health Awards $4 Million to Case Western Reserve University, University Hospitals and Houston Methodist 42

7.4.5 Dec 19, 2024: VSee Health Receives Teleradiology Contract With Post-Acute Care Hospital System 43

7.4.6 Nov 12, 2024: Dr. Noah Biotech Announces Non-clinical Study Results of Donepezil Combination 43

7.4.7 Nov 08, 2024: Cutting-Edge Scans and Diagnostics: Carling Adrenal Center's Guide to Adrenal Health on National Day of Radiology 44

7.4.8 Oct 25, 2024: Abdominal Organ Labeling for Abnormality in CT Reports Using a Large Language Model 46

7.4.9 Jul 24, 2024: Sharing Brain Images Can Foster New Neuroscience Discoveries 46

7.5 Product News 47

7.5.1 Jun 02, 2025: Kalbe and GE HealthCare Announce Launch of CT-Scanner Production Facility 47

7.5.2 Apr 11, 2025: CEUS Offers Safe, Useful Diagnostic Imaging Option for Pregnant Women 47

7.5.3 Feb 26, 2025: Innovative CT Scan Technique Could Improve Prognosis and Treatments for Head and Neck Cancers, New Research Suggests 48

7.5.4 Jan 15, 2025: AI Tool Analyzes 30K Data Points per Medical Imaging Pixel in Cancer Search 49

7.5.5 Nov 11, 2024: Bunkerhill Health AI Powers Cardiovascular Screening at Stamford Health 50

7.5.6 Oct 27, 2024: Positive Long-Term Outcomes with Heartflow Ffrct and Plaque Analysis Demonstrated in Advance-Dk Registry at Tct 2024 50

7.5.7 Oct 07, 2024: Long COVID Patients With Abnormal Lung CT Scans Could Prove Key to Preventing Pulmonary Fibrosis 51

7.5.8 Sep 05, 2024: Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution

0.75% for Presbyopia 52

7.5.9 Sep 04, 2024: Apnimed to Present New Findings on the Prevalence of Obesity Hypoventilation Syndrome (OHS) at the ERS Congress 2024 55

7.5.10 Aug 21, 2024: The STAR Consortium Announces a Major Milestone in Crohn's Disease Intestinal Strictures Imaging 56

7.6 Research And Development 57

7.6.1 Dec 19, 2024: USFDA Issues Complete Response Letter for the Glepaglutide New Drug Application for the Treatment of Short Bowel Syndrome 57

7.7 Strategy And Business Planning 58

7.7.1 May 12, 2025: Fujifilm Strengthens Partnership With the National Rural Health Association To Improve Access to Medical Imaging in Rural Communities 58

7.7.2 Apr 10, 2025: Cincinnati Children’s and GE Healthcare to Form Strategic Research Program 59

7.7.3 Mar 12, 2025: Forest City Diagnostic Imaging Expands Operations, Touts Its MRI AI-powered Technology, and Unveils Its Latest 2024 Siemens CT Scanner 60

7.7.4 Feb 25, 2025: Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms 60

7.7.5 Dec 01, 2024: Canon Medical Systems Expands the Boundaries of CT Imaging 61

7.7.6 Aug 16, 2024: Detect-ION Partners With Moffitt Cancer Center 62

7.7.7 Jul 01, 2024: NURA Health Screening Center Opens in Hanoi, Vietnam 62

8 Appendix 64

8.1 Research Methodology 65

8.1.1 Coverage 65

8.1.2 Secondary Research 65

8.1.3 Primary Research 65

8.1.4 Market Modeling and Forecasting 66

8.1.5 Company Share Analysis 67

8.1.6 Benchmarking 68

8.2 GlobalData Consulting 68

8.3 Contact Us 68

8.4 Disclaimer 69

Table

Table 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033 13

Table 3: Computed Tomography (CT) Systems Market, United States, Average Price ($), 2018-2033 14

Table 4: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2024 17

Table 5: Computed Tomography (CT) Systems Market Pipeline Products 20

Table 6: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032 21

Table 7: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036 23

Table 8: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 66

Figures

Figure 1: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, 2018-2033 9

Figure 2: Computed Tomography (CT) Systems Market, United States, Volume (Units), 2018-2033 12

Figure 3: Computed Tomography (CT) Systems Market, United States, Company Share (%), 2024 16

United States Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

United States Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others in real time.

  • Access a live United States Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more